文献速递神经肿瘤

弥漫性中线颅底脑膜瘤:一种罕见且侵袭性脑膜瘤亚群的识别

Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.
PubMed 文献 · J Neurooncol · 2017-05-23

本文描述了一种弥漫性中线颅底脑膜瘤的临床放射学实体,可导致听力视力丧失、颅内高压、继发性脑积水和扁桃体疝伴脊髓压迫等神经并发症,手术和放疗未能阻止其临床进程;对4例肿瘤行已知突变基因靶向测序,发现2例存在TRAF7突变。

要点

  • 弥漫性中线颅底脑膜瘤虽组织学良性,但临床可呈侵袭性。
  • 该亚群可致听力视力丧失、颅内高压、继发性脑积水及扁桃体疝伴脊髓压迫。
  • 手术和放疗未能阻止该类肿瘤的临床进程,4例中2例检出TRAF7突变。

核心结论

  • 弥漫性中线颅底脑膜瘤是一种罕见且临床侵袭的亚群,手术和放疗未能阻止其临床进程。

研究设计与样本

  • 本文描述了一种弥漫性中线颅底脑膜瘤的临床放射学实体,并对4例肿瘤行已知突变基因的靶向测序。

主要发现

  • 弥漫性中线颅底脑膜瘤可导致听力视力丧失、颅内高压、继发性脑积水和扁桃体疝伴脊髓压迫等神经并发症。
  • 手术和放疗未能阻止该类肿瘤的临床进程。
  • 4例肿瘤中2例检出TRAF7突变。

临床怎么用

  • 作者强调脑膜瘤研究界应重点研究TRAF7相关脑膜瘤肿瘤发生机制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Skull base meningiomas may present as clinically aggressive tumors despite being histologically benign. Here we describe a clinico-radiological entity of diffuse midline skull base meningiomas responsible for several neurological morbidities, including hearing and vision loss, intracranial hypertension, secondary hydrocephalus and tonsillar herniation with spinal cord compression. Surgery and radiotherapy were ineffective in stopping the clinical course of those tumors. After targeted sequencing of known mutated genes in meningiomas, we discovered TRAF7 mutations in two out of four tumors, stressing the importance of focusing the research efforts of the meningioma community in understanding the mechanisms underlying TRAF7 related meningioma tumorigenesis.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Peyre M, Feuvret L, Sanson M, et al. Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas. J Neurooncol. 2017. PMID: 28536991. doi:10.1007/s11060-017-2480-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。